Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-G137775-25 25 µg (0.2 mg/ml) $375 
LS-G137775-100 100 µg $731 
CXCL4 / PF4 Protein - Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.

Human CXCL4 / PF4 Protein (Recombinant) - LS-G137775

Human CXCL4 / PF4 Protein (Recombinant) - LS-G137775

Description:
CXCL4 / PF4 Protein LS-G137775 is a Recombinant Human CXCL4 / PF4. It is biologically active and is low in endotoxin; Less than 0.01 ng/µg (determined by LAL method). For Research Use Only
Price
Catalog Number
$375
LS-G137775-25
Toll Free North America
206-374-1102
For Research Use Only

Overview

Description:
CXCL4 / PF4 Protein LS-G137775 is a Recombinant Human CXCL4 / PF4. It is biologically active and is low in endotoxin; Less than 0.01 ng/µg (determined by LAL method). For Research Use Only

Specifications

Type
Recombinant Protein
Target
CXCL4 / PF4
Synonyms
PF4 | C-X-C motif chemokine 4 | CXCL4 | Iroplact | Oncostatin-A | PF-4 | SCYB4 | Platelet factor 4
Species
Human
Modifications
Carrier-free
Conjugations
Unconjugated
Predicted Molecular Weight
The 70 amino acid recombinant protein has a predicted molecular mass of approximately 7.8 kD. The DTT-reduced and non-reduced protein migrates at approximately 11 kD by SDS-PAGE. The predicted N-terminal amino acid is Glu.
Source Species
E. coli
Purification
Greater than 97% by SDS-PAGE
Usage Summary
Stock solutions can also be prepared at 50-100 µg/mL in sterile buffer (PBS, HPBS, DPBS, or EBSS) containing carrier protein such as 0.2-1% BSA or HSA.
Bio-Activity
The ED50 is 2 - 5 µg/ml, as determined by a dose-dependent inhibition of human FGF-basic-dependent proliferation of HUVEC cells.
Endotoxin
Less than 0.01 ng/µg (determined by LAL method).
Presentation
0.22 µm filtered protein solution in PBS, pH 7.4
Storage
Store unopened at 2°C to 8°C for up to 1 month, at -20°C for up to 6 months, or at -70°C for up to 1 year. Store diluted at -20°C to -70°C. Avoid freeze/thaw cycles. For maximum results, quick spin vial prior to opening.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This protein carries the LSBio 100% Guarantee.
LSBio Guarantee
About CXCL4 / PF4
P02776 NM_002619 NP_002610.1

Publications (0)

Customer Reviews (0)

Images

Proliferation

CXCL4 / PF4 Protein - Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.
Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.

Proliferation

CXCL4 / PF4 Protein - Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.
Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.

Proliferation

CXCL4 / PF4 Protein - Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.
Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.

Proliferation

CXCL4 / PF4 Protein - Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.
Inhibition of human FGF-basic-dependent proliferation of HUVEC by human CXCL4.

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 7/17/2024